190
Participants
Start Date
June 20, 2017
Primary Completion Date
July 27, 2018
Study Completion Date
July 27, 2018
TNX-102 SL
2 x TNX-102 SL, 2.8mg tablets taken daily at bedtime for 12 weeks
New York, New York
Cedarhurst, Cedarhurst
Charleston, Charleston
Atlanta, Atlanta
Jacksonville, Jacksonville
Lake City, Lake City
Lauderhill, Lauderhill
Tampa, Tampa
Flowood, Flowood
Canton, Canton
Cincinnati, Cincinnati
Dayton, Dayton
Rogers, Rogers
Oklahoma City, Oklahoma City
Dallas, Dallas
Houston, Houston
San Antonio, San Antonio
Austin, Austin
Colorado Springs, Colorado Springs
Phoenix, Phoenix
Las Vegas, Las Vegas
Beverly Hills, Beverly Hills
Glendale, Glendale
Oceanside, Oceanside
San Diego, San Diego
San Diego, San Diego
Riverside, Riverside
Temecula, Temecula
Orange, Orange
Oakland, Oakland
New Bedford, New Bedford
Berlin, Berlin
Collaborators (1)
Premier Research Group plc
UNKNOWN
Tonix Pharmaceuticals, Inc.
INDUSTRY